MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer

T. Ujihira, K. Ikeda, T. Suzuki, R. Yamaga, W. Sato, K. Horie-Inoue, T. Shigekawa, A. Osaki, T. Saeki, K. Okamoto, S. Takeda, S. Inoue

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)


Most primary breast cancers express estrogen receptor a and can be treated via endocrine therapy using anti-estrogens such as tamoxifen; however, acquired endocrine resistance is a critical issue. To identify tamoxifen response-related microRNAs (miRNAs) in breast cancer, MCF-7 cells infected with a lentiviral miRNA library were treated with 4-hydroxytamoxifen (OHT) or vehicle for 4 weeks, and the amounts of individual miRNA precursors that had integrated into the genome were evaluated by microarray. Compared to the vehicle-treated cells, 5 'dropout' miRNAs, which were downregulated in OHT-treated cells, and 6 'retained' miRNAs, which were upregulated in OHT-treated cells, were identified. Of the dropout miRNAs, we found that miR-574-3p expression was downregulated in clinical breast cancer tissues as compared with their paired adjacent tissues. In addition, anti-miR-574-3p reversed tamoxifen-mediated suppression of MCF-7 cell growth. Clathrin heavy chain (CLTC) was identified as a miR-574-3p target gene by in silico algorithms and luciferase reporter assay using the 39 untranslated region of CLTC mRNA. Interestingly, loss and gain of miR-574-3p function in MCF-7 cells causes CLTC to be upregulated and downregulated, respectively. These results suggest that functional screening mediated by miRNA libraries can provide new insights into the genes essential for tamoxifen response in breast cancer.

Original languageEnglish
Article number7641
JournalScientific reports
Publication statusPublished - 2015 Jan 6
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer'. Together they form a unique fingerprint.

Cite this